US Federal Judge orders Alfasigma to stop false claims. VSL#3® has never been studied in IBD, IBS, liver diseases or any other disease.
On November 18, 2018, the Maryland Court of Justice condemned the pharmaceutical companies, VSL. Inc., Leadiant and Alfasigma, distributors of the probiotic VSL#3, to pay $15 million for false advertising and having deceived patients and doctors. As a result of this court decision, scientific authorities now recognize the De Simone Formulation [...]
A federal jury in the United States District Court for the District of Maryland unanimously ruled on Nov. 18 in favor of myself and ExeGi Pharma, which distributes my Formulation in the US, against VSL Inc, Leadiant and Alfasigma, for False Advertising, Unjust Enrichment and Unpaid Royalties. The jury unanimously found [...]